Bench to Bedside

  • Advancing molecular life sciences into next generation bio-inspired therapies at the interface of degeneration and regeneration with a mayor focus on the most relevant human diseases, including neuro-degeneration and cardiovascular disease


  • Creating synergies for bio-inspired regenerative therapies by combining existing technology platforms for recombinant human monoclonal antibodies with cell-based regeneration systems including tissue engineering, stem cells, organoid Technologies


  • Jointly leveraging the translational development process and key clinical translation milestones such as prevention, therapy, regeneration, and imaging


  • Translation: regenerative medicine technologies into university spin-off companies e.g. memocare and Neurimmune